Het voorbereiden en toedienen van geïnhaleerde medicijnen
View the full transcript and gain access to JoVE Science Education videos
Q1: What conditions require inhaled medication therapy?
Inhaled medications treat acute conditions like bronchitis, pneumonia, and pulmonary edema, as well as chronic conditions including asthma, chronic bronchitis, emphysema, cystic fibrosis, and lung cancer. These medications target the bronchi and bronchioles to open airways, decrease inflammation, and promote airflow throughout the respiratory system.
Q2: Why is direct airway delivery preferred for inhaled medications?
Delivering medications directly into the airways produces a faster therapeutic response compared to systemically administered medications. This targeted approach also significantly decreases the impact of systemic side effects, making inhaled administration more efficient and safer for patients requiring respiratory treatment.
Q3: What are the main types of inhaled medication delivery devices?
Common inhaled delivery devices include metered-dose inhalers, dry-powder inhalers, and breath-activated inhalers. These devices use chemical propellants, deep inhalation, or fine mist to deliver short- and long-acting bronchodilators and corticosteroids directly to the lower bronchi and bronchioles for optimal therapeutic effect.
Q4: How does a spacer device improve metered-dose inhaler use?
A spacer is a device that helps patients coordinate breathing with medication release from a metered-dose inhaler. It is particularly useful for patients who have difficulty inhaling medications into the lower airways, ensuring more effective delivery of the medication to the target respiratory structures.
Q5: What assessments should be completed before administering inhaled medications?
A thorough respiratory assessment must be completed prior to inhaled medication administration to ensure the medication and delivery device are appropriate for the patient's condition and that the patient can comply with the administration procedure. Patient education about the inhalation process is also essential before beginning treatment.
Q6: What is the difference between acute and chronic respiratory conditions treated with inhaled medications?
Acute respiratory conditions have quick onset and temporary symptoms, including bronchitis, pneumonia, and pulmonary edema. Chronic conditions persist with recurrent symptoms lasting months to years, such as asthma, emphysema, and cystic fibrosis. Both require inhaled medications but differ in duration and treatment approach.
Q7: Why is patient education important before administering inhaled medications?
Inhaled medications require administration coordinated with the breathing cycle, making patient education critical for successful treatment. Patients must have a working understanding of the inhalation procedure before beginning medication administration to ensure proper technique and optimal medication delivery to the airways.